<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8BC88D56-0B5B-4A03-BB32-240AFB788165"><gtr:id>8BC88D56-0B5B-4A03-BB32-240AFB788165</gtr:id><gtr:name>Szeged University</gtr:name><gtr:address><gtr:line1>Szeged University</gtr:line1><gtr:line2>Dugonics ter 13</gtr:line2><gtr:line4>Szeged</gtr:line4><gtr:postCode>H-6720</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Hungary</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2A80FFDA-3B8B-43BA-80C3-3AA850B49BA1"><gtr:id>2A80FFDA-3B8B-43BA-80C3-3AA850B49BA1</gtr:id><gtr:name>University of the West of England</gtr:name><gtr:address><gtr:line1>Coldharbour Lane</gtr:line1><gtr:line2>Frenchay</gtr:line2><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS16 1QY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8BC88D56-0B5B-4A03-BB32-240AFB788165"><gtr:id>8BC88D56-0B5B-4A03-BB32-240AFB788165</gtr:id><gtr:name>Szeged University</gtr:name><gtr:address><gtr:line1>Szeged University</gtr:line1><gtr:line2>Dugonics ter 13</gtr:line2><gtr:line4>Szeged</gtr:line4><gtr:postCode>H-6720</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Hungary</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2A80FFDA-3B8B-43BA-80C3-3AA850B49BA1"><gtr:id>2A80FFDA-3B8B-43BA-80C3-3AA850B49BA1</gtr:id><gtr:name>University of the West of England</gtr:name><gtr:address><gtr:line1>Coldharbour Lane</gtr:line1><gtr:line2>Frenchay</gtr:line2><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS16 1QY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C4B4329E-A731-4BC2-8CFC-7311340846E0"><gtr:id>C4B4329E-A731-4BC2-8CFC-7311340846E0</gtr:id><gtr:firstName>Elek</gtr:firstName><gtr:surname>Molnar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/54913D9C-BD57-4B12-814F-358CAFD24B9F"><gtr:id>54913D9C-BD57-4B12-814F-358CAFD24B9F</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Jane</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ015938%2F1"><gtr:id>CAE18BB7-B25D-44A8-A8FD-588D82B2F3B1</gtr:id><gtr:title>Development of biotin-tagged affinity ligands and fluorophore-conjugated probes for the study of native kainate receptors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J015938/1</gtr:grantReference><gtr:abstractText>The social burden and cost of brain disorders is enormous, and no serious progress can be expected in the treatment or the prevention of these disorders without better understanding of the way neuronal activity is regulated in the central nervous system. Neurones communicate via proteins known as neurotransmitter receptors. Nearly all of the excitatory neurotransmitter receptors in the brain are activated by the amino acid glutamate. Glutamate is released from neurones at synapses in a highly regulated and activity dependent manner. There are several different classes of receptors which respond to glutamate. The least well characterised of these are the kainate receptors (KARs). 

KARs regulate the activity of neuronal networks, which is essential for normal brain function. They are also involved in neuronal development and neurological conditions such as epilepsy, chronic pain, migraine, schizophrenia and neurodegeneration and they represent a potential target for therapeutic drug design. Drug discovery efforts aimed at identifying new and potentially therapeutic compounds rely on detailed knowledge of the molecular composition, structure and pharmacological properties of the neurotransmitter receptors to which new compounds are targeted. Over the last few years, it has become clear that receptor proteins operate within a complex web of interactions with other proteins. Many interactions serve to modulate the transport, localisation and mobility of receptor proteins, while others affect their acute functioning and pharmacological properties. Many proteins have been found to interact with glutamate receptors. This gives rise to complex protein-protein interactions that can have a profound effect on synaptic function. However, the general principles that govern the modulation of the function and pharmacological properties of native KARs by their interaction partners in different types of neurones in various brain regions are not clear. It is important to gain more information about KAR associated proteins, because increased understanding of the mechanisms that regulate KARs will allow their involvement in normal brain function and neurological disorders to be better defined.

In this research project we aim to define the molecular organisation, distribution, protein interactions, pharmacological properties and regulation of KARs in the central nervous system by using newly developed compounds into affinity probes. Based on molecular modelling of KAR interactions with various drugs we will design, synthesise and characterise new pharmacological reagents, which specifically bind to KARs with high affinity and can be used for the selective identification, isolation and analysis of the native receptors and protein interaction partners directly in brain samples. These new pharmacological tools will be used to isolate KARs and associated proteins. The systematic analysis of these isolated protein complexes will provide basic information about the molecular composition, interactions and regulation of KARs in different functionally important regions of the brain and subcellular compartments of neurones. It is very likely that some of the interaction partners (called auxiliary subunits) significantly influence the pharmacological properties of KARs and this may have important implications for drug development. Therefore, we will establish the effects of auxiliary subunits on the pharmacological properties of KARs.

The results of the proposed studies may help the future development of therapeutic agents for the treatment of epilepsy, chronic pain, migraine, schizophrenia and neurodegenerative diseases. Many of these disorders currently have no effective treatments and are extremely deleterious to the health and wealth of the nation.</gtr:abstractText><gtr:technicalSummary>Kainate receptors (KARs) are ligand gated ion channels that are activated by the major excitatory neurotransmitter glutamate and they are key players in the modulation of neuronal-network activity throughout the central nervous system (CNS). Furthermore, KARs play an important role in neuronal differentiation, synaptic plasticity, epileptogenesis, chronic pain, migraine, schizophrenia and neurodegeneration. Recently developed drugs and transgenic mice in combination with electrophysiological studies highlighted the functional significance of KARs in several brain regions, but studies often produced conflicting results. Discrepancies between the functional and pharmacological characteristics of recombinant versus native receptors suggest the existence of important modulatory components in neurones that can influence essential properties of KARs. While several studies identified individual interaction partners for KARs, the molecular composition of the native KARs in neurones are poorly understood. Some of these interaction partners (e.g. auxiliary subunits) are likely to have major effects on the pharmacological properties of KARs that are likely to explain conflicting functional observations. We will use molecular modelling to develop new high affinity ligands for the isolation and localisation of native KARs and their interaction partners. We will apply these affinity ligands in combination with proteomics and immunochemical analysis of isolated KAR complexes to establish regional, cell-type and subcellular compartment specific differences in KAR-interacting proteins. We will also study the effects of different auxiliary subunits on the pharmacological properties of KARs. Better understanding of the KAR associated functional protein network and molecular interactions will ultimately provide better understanding of these receptors as pharmacological targets which could be considered for future treatment strategies.</gtr:technicalSummary><gtr:potentialImpactText>Understanding how the brain works by regulating neuronal activity is a topic of great public and academic interest. The somewhat elusive kainate receptors (KARs) play a key role in the regulation of neuronal activity. The recent discovery of the structure of KAR ligand binding sites created exciting new opportunities for rational drug design and the development of new, more potent and selective pharmacological reagents for the analysis of endogenous KARs and their complex interactions in their native environment in neurones. This project is thus timely and should have major impact at both academic and social levels. To deliver that impact, it is important that the research is disseminated as effectively as possible. The target audiences are academics, pharmaceutical industry, health professionals, schools and the wider public.

ACADEMICS: The various ways neuroscientists, neuropharmacologists, postdoctoral scientists employed on the project and the very wide range of undergraduate and postgraduate student benefit from this project are described under 'Academic beneficiaries'. 

PHARMACEUTICAL INDUSTRY: Mutually beneficial collaborations with industry is an integral part of the way that we achieve our aims. DEJ has worked as a consultant for Eli Lilly's project to develop KAR antagonists for the treatment of a range of neurological disorders and has been a member of Lilly's Centre for Cognitive Neuroscience since its inception in 2008. DEJ has close links with biotechnology companies (Ascent Scientific and Tocris Biosciences). These established collaborations will be used to commercialise and distribute new research tools developed during this project (high affinity GluK1 selective antagonists, biotinylated affinity ligands and fluorophore-conjugated probes) to the wider research community. Furthermore, there is significant interest in KARs by industry as potential drug targets for epilepsy, schizophrenia, neurodegenerative disorders, migraine and chronic pain therefore our results are likely to have an impact in this area.

HEALTH PROFESSIONALS: Because KARs have been linked to a range of neurological disorders where effective treatment is currently unavailable, they offer inviting possibilities for therapeutic exploitation. However, a much better understanding of KARs will be essential for the development of new therapies. Therefore, the medical community will also benefit from any new developments in the field.

SCHOOLS: The future of science depends on enthusiastic young scientists. Both applicants are involved in University open days, making explanation of science accessible to prospective students and parents.

THE WIDER PUBLIC: Both applicants are committed to engage public interest and to shape public perception about the benefits of scientific discovery. We will take every opportunity to directly engage the public and schools through initiatives coordinated by the Bristol University Centre for Public Engagement, Bristol Neuroscience and by local attractions (e.g. the children's science activity centre '@Bristol'). Our published findings will be promoted to the public through Bristol Neuroscience and the University Press Office.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>646155</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Cellular and Molecular Medicine</gtr:department><gtr:description>The effects of nutrient stress on LGR5 receptor</gtr:description><gtr:id>BF62EF3C-AA67-4195-9B16-781007E01391</gtr:id><gtr:impact>Paper: 25611300</gtr:impact><gtr:outcomeId>56d821c75ec229.38504869-1</gtr:outcomeId><gtr:partnerContribution>My partner performed most of the experiments and financed the study.</gtr:partnerContribution><gtr:piContribution>Contribution to the design of a study which identified that nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tutor cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of the West of England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Association between altered glutamatergic signalling and birth conditions</gtr:description><gtr:id>44BC9070-1865-4574-B7BA-34F4A1A08204</gtr:id><gtr:impact>Smith-Collins A, Heep A, Kauppinen R, Varadi A, Rajatileka S, Molnar E, Luyt K (2014) 5.8 clinical and genetic influences on functional brain networks in preterm infants. Arch Dis Child Fetal Neonatal Ed 99(S1):5.8. Perinatal Medicine 2014, Harrogate, UK</gtr:impact><gtr:outcomeId>56d8242b411339.09207396-2</gtr:outcomeId><gtr:partnerContribution>Carried out data analysis, contributed to study design, interpretation of the data and the preparation of the manuscript.</gtr:partnerContribution><gtr:piContribution>Contributed to study design, interpretation of the data and the preparation of the manuscript.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Sciences</gtr:department><gtr:description>Association between altered glutamatergic signalling and birth conditions</gtr:description><gtr:id>D3EF6E6F-0FE3-4F31-A710-FB5CBC35F590</gtr:id><gtr:impact>Smith-Collins A, Heep A, Kauppinen R, Varadi A, Rajatileka S, Molnar E, Luyt K (2014) 5.8 clinical and genetic influences on functional brain networks in preterm infants. Arch Dis Child Fetal Neonatal Ed 99(S1):5.8. Perinatal Medicine 2014, Harrogate, UK</gtr:impact><gtr:outcomeId>56d8242b411339.09207396-1</gtr:outcomeId><gtr:partnerContribution>Carried out data analysis, contributed to study design, interpretation of the data and the preparation of the manuscript.</gtr:partnerContribution><gtr:piContribution>Contributed to study design, interpretation of the data and the preparation of the manuscript.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Szeged</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>Repeated seizure-induced changes in ionotropic glutamate receptors</gtr:description><gtr:id>940F084F-D35D-4E88-BA73-053C2D171173</gtr:id><gtr:impact>Publications: 19154779, 19445932, 25576253</gtr:impact><gtr:outcomeId>F3D26CA0FCC-1</gtr:outcomeId><gtr:partnerContribution>Expertise with the use of different animal models of epilepsy</gtr:partnerContribution><gtr:piContribution>I have provided major intellectual input, reagents, training in methodology, help with experiments, data analysis and preparation of manuscripts</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of the West of England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Single nucleotide polymorphisms in the EAAT2 glutamate transporter gene are associated with cerebral palsy in preterm infants</gtr:description><gtr:id>42A6749C-90B6-484B-97A7-BC8F26907DA4</gtr:id><gtr:impact>Papers: 24168095, 24996834</gtr:impact><gtr:outcomeId>56d818a1b09874.76931891-1</gtr:outcomeId><gtr:partnerContribution>UWE awarded &amp;pound;150000 for the project, provided facilities and joint supervision for the Postdoctoral Researcher.</gtr:partnerContribution><gtr:piContribution>I have contributed to the investigation of the role of two closely linked functional SNPs in the EAAT2 gene promoter in susceptibility to brain injury and neurodisability in preterm infants born before 32 weeks gestation. I have jointly supervised a Postdoctoral Researcher and contributed to the design of the study.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of the West of England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Kainate receptors in pancreatic endocrine cells</gtr:description><gtr:id>136223D4-8054-4421-B232-86F6339CF533</gtr:id><gtr:impact>Conference presentations:
Dwomoh L, Whitehead G, Spittle A, Luxton R, Molnar E, Varadi A (2014) Kainate receptors (KARs) in pancreatic endocrine cells. Islet Study Group 2014 Meeting Pancreatic Islet Cell Plasticity in Health and Diabetes, Lausanne, Switzerland

Dwomoh L, Whitehead G, Spittle A, Molnar E, Varadi A (2015) Molecular composition, function and physiology of kainate receptors (KARs) in pancreatic endocrine cells. FEBS J 282:137-138.</gtr:impact><gtr:outcomeId>56d81d70e61a36.99826645-1</gtr:outcomeId><gtr:partnerContribution>Award of a PhD studentship, project design and joint supervision of a PhD student.</gtr:partnerContribution><gtr:piContribution>Project design and joint supervision of a PhD student.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>European Parliament Scientific Foresight Unit's MEP-Scientist Pairing Scheme</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F169DD1B-F0A3-4CBC-A917-61FBE3733B63</gtr:id><gtr:impact>The 'MEP-Scientist Pairing Scheme', run by the European Parliament's Science and Technology Options Assessment (STOA) Panel, aims at promoting a culture of science-based policy-making by helping create lasting links between scientists and Members of the European Parliament (MEPs). The essence of this project is to establish a structured dialogue between scientists and policy-makers, with the aim to raise awareness about politically relevant, cutting-edge scientific issues and about the importance of science for evidence-informed policy-making.</gtr:impact><gtr:outcomeId>56d846988aa015.63799712</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.europarl.europa.eu/stoa/cms/home/activities/mepscientist</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture: Gwangju International Neuroscience Symposium, Chonnam National University Hospital, Gwangju, Korea</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0C8224D7-510B-4D07-826D-34FF856FEDCF</gtr:id><gtr:impact>Invited lecture at the Gwangju International Neuroscience Symposium, Chonnam National University Hospital, Gwangju, Korea

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-3025619613.96189360cc5bd50</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Investigation of glutamate receptors using immunochemical techniques</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>58F7DCC4-F973-4AB7-8057-7AEAA5996E74</gtr:id><gtr:impact>Abcam&amp;reg; Scientific webinar (February 5, 2014)

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-8259383950.6240410cd73e72</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:url>http://www.abcam.com/events/investigation-of-glutamate-receptors-using-immunochemical-techniques-free-webinar</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brambell Translational Neuroscience Seminar, University of Bristol</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>57624D5A-81C8-488A-B720-2742030312E0</gtr:id><gtr:impact>'Molecular organisation of kainate receptors', The Brambell Translational Neuroscience Seminar Series, University of Bristol

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-6270480813.7104670cc3e9b2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar: Clinical Science at North Bristol, Southmead Hospital, University of Bristol</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2C91536F-029D-48B1-8B34-A6D1F8AFE2B3</gtr:id><gtr:impact>Invited neuroscience seminar at Southmead Hospital (Clinical Science at North Bristol, University of Bristol)

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-3907412899.57185550cd7a164</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'The Importance of Research in Neuroscience' STOA Workshop, European Parliament, Brussels</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7BA4FE70-A65A-41C2-83B4-030EB2BB3F37</gtr:id><gtr:impact>This workshop was organised by the Science and Technology Options Assessment (STOA) Group of the European Parliament Research Service to to inform MEPs regarding the importance and challenges of neuroscience research in Europe.</gtr:impact><gtr:outcomeId>56d84923456804.67625287</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.europarl.europa.eu/stoa/cms/cache/offonce/home/workshops/neuroscience</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain Awareness Week @Bristol</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1B83748F-BF24-444E-95CA-8CB169B8735E</gtr:id><gtr:impact>Interactive Brain Awareness Week exhibitions. This is an annual event organised in conjunction with the children's science activity centre @Bristol, in which neuroscientists can engage local children and their parents through experimental demonstrations and one-to-one dialogue to promote understanding of how the brain works.

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-6685896484.8200750cdbb380</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dana.org/baw/</gtr:url><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>646155</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J015938/1</gtr:fundingRef><gtr:id>E58AE57F-9C6C-46EC-8542-09F0004590E9</gtr:id><gtr:outcomeId>dTtQUeUcXEn</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Collaboration with a new life science company (HelloBio, http://www.hellobio.com) regarding the translation of our results into products.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>F31F691F-3BB6-4206-A5D7-CB5EF985A644</gtr:id><gtr:impactTypes><gtr:impactType>Cultural,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>544fa49f9c6ec9.00139889</gtr:outcomeId><gtr:sector>Education,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The major focus of this grant was the design, synthesis and characterisation of new pharmacological tools for kainate receptors (KARs). Molecular modelling studies allowed the design of a panel of new KAR antagonists and affinity ligands with improved subunit selectivity and affinity. The new affinity ligands contain a UV sensitive moiety at a position that reacts with residues in the GluK1 ligand binding domain and a polyethylene glycol linker with a biotin group that projects out of the LBD and available to bind to avidin. 

Our studies indicate that the new antagonists (UBP3000-3002) are suitable for functional studies of GluK1 subunit containing KARs. The new biotin-tagged photoaffinity ligands (UBP326 and UBP327) were used to perform biochemical studies of KARs in both mammalian cell lines and brain tissue. Our findings show that UBP326 and UBP327 can isolate GluK1 subunit-containing KARs. The ability to covalently label and isolate recombinant and native GluK1 KAR proteins created new opportunities for the identification of the molecular composition of native KAR complexes. We have also successfully used UBP326 and UBP327 to label GluK1 receptors in stably-transfected GluK1 expressing cells, which were visualised using fluorescence microscopy. Thus, our data indicate that the new affinity probes are useful pharmacological tools for isolation and investigation of the function of GluK1 subunit containing KARs. The developed new experimental tools and strategies will be applied for the investigation of activity-dependent changes in KAR molecular compositions in our future studies. 

Following the optimisation of the photo-labelling procedures, our work focused on the use of the new affinity probes in combination with previously developed immunochemical reagents for the investigation of recombinant and native KARs and their auxiliary subunits in different subcellular compartments. These studies provided information about the differential distribution of channel pore forming and auxiliary subunits. We have also established, that the cell surface expression of Neto1 and Neto2 is glycosylation dependent and identified the relevant glycosylation sites. Furthermore, we have identified a new endoplasmic reticulum (ER) retention motif in Neto2, which explains some of our findings: While Neto1 is effectively trafficked to the cell surface, Neto2 surface expression requires the presence of GluK2. Without co-expression with GluK2, Neto2 is retained in the ER.

In conjunction with our pharmacological studies of KARs, we have also investigated the effects of the auxiliary proteins Neto1/Neto2 on GluK2 trafficking and surface expression. Our data suggests that Neto proteins have differential effects on the membrane expression of KAR subunits. Co-expressing Neto1/Neto2 and KARs in HEK293, and utilising endocytic biotinylation and degradation assays, we found that Neto proteins differentially modulate GluK2 subunit endocytosis from the plasma membrane, with Neto2 increasing the rate of endocytosis in basal conditions and following treatment with the agonist kainate, whilst Neto1 had no effect. Moreover, Neto2 decreased the degradation of GluK2 receptors in basal conditions, but not in kainate stimulated cells. This data reveals a potential role for Neto2 proteins in the regulation of KARs at the cell surface by altering the endocytosis and degradation rates of KAR subunit proteins.</gtr:description><gtr:exploitationPathways>The developed pharmacological tools and photoaffinity labelling procedures can be used for a wide range of functional and molecular studies.</gtr:exploitationPathways><gtr:id>0633A6C6-DD42-416F-A5DC-AD0B8612E923</gtr:id><gtr:outcomeId>544fab2fc46327.80828244</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Training of BSc in Neuroscience students</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>B43E309E-B3DD-4C08-9A60-EA78490260AD</gtr:id><gtr:impact>The final year 'Synaptic Cell Biology' and 'Neurological and Psychiatric Disorders' Units were directly informed by our research. Also, the 6 undergraduate research project students worked on related areas in our lab.</gtr:impact><gtr:outcomeId>58c182b8b79fc0.57099698</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MBChB Nervous System Element Organiser</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>A3B5A562-D479-41E5-816E-4C6E5F35CC99</gtr:id><gtr:outcomeId>RtejGwXVX4e</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Skills training of PhD students</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>ABA6181D-1C8E-4D52-9850-6EF7EC57A623</gtr:id><gtr:impact>These annual skills development sessions provided training in key methodologies for about 30 PhD students at the Faculty of Biomedical Sciences, University of Bristol.</gtr:impact><gtr:outcomeId>58c1811fdc4972.07485251</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I have developed a panel of unique antibodies suitable for the biochemical analysis and cellular and subcellular visualization of various native ionotropic glutamate receptor (iGluR) subunit proteins in living cultured neurones and in brain tissue. These immunoreagents were extensively used for the analysis of iGluR distribution and to gain some understanding of the rules neurones follow during the assembly and cell surface targeting of iGluRs and the mechanism by which synaptic input controls a neurone's ability to modify its synapses. This is one of the most extensively studied areas in neuroscience, and I receive numerous requests to supply various laboratories worldwide with my antibodies. Our results and experimental protocols are described in several high profile and widely cited publications (listed below under impact). The development and detailed characterisation of these antibodies in different experimental systems are extremely time consuming, labour intensive and costly processes which often take years.</gtr:description><gtr:id>A58FF0DA-10BE-4BC8-947A-4F3A2E9C9683</gtr:id><gtr:impact>PubMed IDs of some of the papers where these antibodies were used: 19895665, 19828804, 19445932, 19154779, 19063969, 18923032, 18815255, 17395218, 17314308, 17156361, 16775145</gtr:impact><gtr:outcomeId>F2D41A55731</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Immunoreagents for the investigation of glutamate receptors</gtr:title><gtr:type>Antibody</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19895665</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Based on molecular modelling studies using our published X-ray crystal structures of antagonists bound to the ligand binding domain (LBD) of GluK1 kainate receptor subunit, we have designed and synthesised a panel of new antagonists (UBP3000-3005) with improved subunit selectivity and affinity.</gtr:description><gtr:id>DF6B2B1C-1144-45E2-8962-7E51698EB690</gtr:id><gtr:impact>Manuscripts are in preparation.</gtr:impact><gtr:outcomeId>56d856b7d5cff2.40655658</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New kainate receptor antagonists</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed two new affinity ligands (UBP326, UBP327) with improved subunit selectivity and affinity. The new affinity ligands contain a UV sensitive moiety at a position that reacts with residues in the GluK1 LBD and a polyethylene glycol (PEG) linker with a biotin group that projects out of the LBD and available to bind to avidin. Our findings show that UBP326 and UBP327 can isolate GluK1 receptors from both HEK293 cells expressing recombinant GluK1 receptors and native KARs from rat brain tissue.</gtr:description><gtr:id>EDD41364-E472-4525-A759-4E22FDE5219E</gtr:id><gtr:impact>Manuscript in preparation.</gtr:impact><gtr:outcomeId>56d857d76f3ef8.08771660</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New affinity ligands for kainate receptors</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F9269194-398D-4EDC-BB4B-B945AA7D4CA6</gtr:id><gtr:title>Signalling and crosstalk of AMPA/Kainate, mGlu5 and GABA(B) receptors in oligodendrocyte precursor cells</gtr:title><gtr:parentPublicationTitle>JOURNAL OF NEUROCHEMISTRY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/894f077f8b8fc683106d39509f105865"><gtr:id>894f077f8b8fc683106d39509f105865</gtr:id><gtr:otherNames>Molnar E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>56ca034cbc50f4.01626773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>785CD714-90DB-43C2-A005-137B505C77FB</gtr:id><gtr:title>New tool to tackle Alzheimer's disease: amyloid-? protofibril-selective antibody AbSL: An Editorial Highlight for 'The conformational epitope for a new A?42 protofibril-selective antibody partially overlaps with the peptide N-terminal region' on page 736.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96e43fe3ab77352db7886a85b9ddb0c9"><gtr:id>96e43fe3ab77352db7886a85b9ddb0c9</gtr:id><gtr:otherNames>Moln?r E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>5a2fce4eef3885.29898324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F93869-291F-4D64-BDB7-2C6F303A3CFE</gtr:id><gtr:title>Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d05e359057f815a4d3cdfd804a76b135"><gtr:id>d05e359057f815a4d3cdfd804a76b135</gtr:id><gtr:otherNames>Morgan RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5675ded81433c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04678916-630D-4823-9592-169F144FE991</gtr:id><gtr:title>Essential Guide to Reading Biomedical Papers - Recognising and Interpreting Best Practice</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96e43fe3ab77352db7886a85b9ddb0c9"><gtr:id>96e43fe3ab77352db7886a85b9ddb0c9</gtr:id><gtr:otherNames>Moln?r E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-1199-5996-0</gtr:isbn><gtr:outcomeId>r_791618073491d71a78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE894DA6-8DB9-42BB-B8AA-B176691960F9</gtr:id><gtr:title>Are Neto1 and APP auxiliary subunits of NMDA receptors?</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96e43fe3ab77352db7886a85b9ddb0c9"><gtr:id>96e43fe3ab77352db7886a85b9ddb0c9</gtr:id><gtr:otherNames>Moln?r E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_14680_20_23815265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5865A43-4398-4C3C-BBAE-448DD3CAC4D5</gtr:id><gtr:title>MyRIP interaction with MyoVa on secretory granules is controlled by the cAMP-PKA pathway.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/128d164b4b408456a4507c46b9fef470"><gtr:id>128d164b4b408456a4507c46b9fef470</gtr:id><gtr:otherNames>Brozzi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>doi_55f94b94b369bde3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EB4D666-7F65-4A1B-94E8-EB4D43AE3BFF</gtr:id><gtr:title>Essential Guide to Reading Biomedical Papers - Recognising and Interpreting Best Practice</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96e43fe3ab77352db7886a85b9ddb0c9"><gtr:id>96e43fe3ab77352db7886a85b9ddb0c9</gtr:id><gtr:otherNames>Moln?r E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>LTxFSqyuxux</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63A0CF1B-787D-40EF-A962-567B25E2402C</gtr:id><gtr:title>Isolation of human genomic DNA for genetic analysis from premature neonates: a comparison between newborn dried blood spots, whole blood and umbilical cord tissue.</gtr:title><gtr:parentPublicationTitle>BMC genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39c79486d00736d1ba52aa86375130be"><gtr:id>39c79486d00736d1ba52aa86375130be</gtr:id><gtr:otherNames>Rajatileka S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2156</gtr:issn><gtr:outcomeId>pm_5435b0b5b0b88f706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>623613EB-CBA4-4CFC-8059-86778D32EF3B</gtr:id><gtr:title>The number and distribution of AMPA receptor channels containing fast kinetic GluA3 and GluA4 subunits at auditory nerve synapses depend on the target cells.</gtr:title><gtr:parentPublicationTitle>Brain structure &amp; function</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a511b7b345e672b7768a259262aecb49"><gtr:id>a511b7b345e672b7768a259262aecb49</gtr:id><gtr:otherNames>Rubio ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1863-2653</gtr:issn><gtr:outcomeId>5a2fce21ef1c55.42710488</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33056E30-8023-4BCD-B2AA-37A9687EBA1B</gtr:id><gtr:title>Molecular composition, function and physiology of Kainate Receptors (KARs) in pancreatic endocrine cells</gtr:title><gtr:parentPublicationTitle>FEBS JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f1c73b17d7a9fe671b9a8710a41cfcb"><gtr:id>9f1c73b17d7a9fe671b9a8710a41cfcb</gtr:id><gtr:otherNames>Dwomoh L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>56ca034ce2d194.02393901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC63CEDC-B863-4E14-B9D8-F88B97A3ABA3</gtr:id><gtr:title>Variants of the EAAT2 Glutamate Transporter Gene Promoter Are Associated with Cerebral Palsy in Preterm Infants.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39c79486d00736d1ba52aa86375130be"><gtr:id>39c79486d00736d1ba52aa86375130be</gtr:id><gtr:otherNames>Rajatileka S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>58c16ed0a3d049.32382327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67F2395B-3D82-4A4F-A32E-1033704C0A9D</gtr:id><gtr:title>Detection of three closely located single nucleotide polymorphisms in the EAAT2 promoter: comparison of single-strand conformational polymorphism (SSCP), pyrosequencing and Sanger sequencing.</gtr:title><gtr:parentPublicationTitle>BMC genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39c79486d00736d1ba52aa86375130be"><gtr:id>39c79486d00736d1ba52aa86375130be</gtr:id><gtr:otherNames>Rajatileka S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2156</gtr:issn><gtr:outcomeId>544f9c02ec5001.42414590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D5B6320-D69D-45C2-B54A-C0D4979DAF35</gtr:id><gtr:title>Association between neonatal resuscitation and a single nucleotide polymorphism rs1835740.</gtr:title><gtr:parentPublicationTitle>Acta paediatrica (Oslo, Norway : 1992)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48c93f7b1429374da633ca977d4cda48"><gtr:id>48c93f7b1429374da633ca977d4cda48</gtr:id><gtr:otherNames>Odd D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0803-5253</gtr:issn><gtr:outcomeId>585d3bd77db048.67081876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6B8D22B-5249-4610-B6CC-5D65563D3349</gtr:id><gtr:title>The NMDA receptor as a target for cognitive enhancement.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8606ab1418d621c0ce28e517cb05f051"><gtr:id>8606ab1418d621c0ce28e517cb05f051</gtr:id><gtr:otherNames>Collingridge GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>pm_14680_20_22796429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20D9CF47-D927-419F-9882-016EA301917D</gtr:id><gtr:title>Repeated application of 4-aminopyridine provoke an increase in entorhinal cortex excitability and rearrange AMPA and kainate receptors.</gtr:title><gtr:parentPublicationTitle>Neurotoxicity research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abb7ebedb88fc37fb9a8d6f351dea032"><gtr:id>abb7ebedb88fc37fb9a8d6f351dea032</gtr:id><gtr:otherNames>Borb?ly S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1029-8428</gtr:issn><gtr:outcomeId>5675de74bf7e4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48413359-09DF-4DF8-BBDE-3D1E6EF7D2D9</gtr:id><gtr:title>Arctigenin reduces neuronal responses in the somatosensory cortex via the inhibition of non-NMDA glutamate receptors.</gtr:title><gtr:parentPublicationTitle>Neurochemistry international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abb7ebedb88fc37fb9a8d6f351dea032"><gtr:id>abb7ebedb88fc37fb9a8d6f351dea032</gtr:id><gtr:otherNames>Borb?ly S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-0186</gtr:issn><gtr:outcomeId>585d361cf04270.35130504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2472A8E-175F-4B30-AE8D-58F58C06DFA2</gtr:id><gtr:title>Essential Guide to Reading Biomedical Papers - Recognising and Interpreting Best Practice</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96e43fe3ab77352db7886a85b9ddb0c9"><gtr:id>96e43fe3ab77352db7886a85b9ddb0c9</gtr:id><gtr:otherNames>Moln?r E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-1199-5996-0</gtr:isbn><gtr:outcomeId>r_187626895391d71d98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>306367FB-6A6C-4812-B047-0DDC685AC250</gtr:id><gtr:title>Is riluzole a new drug for Alzheimer's disease?</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c50291f7b002aa9996e49965c0704865"><gtr:id>c50291f7b002aa9996e49965c0704865</gtr:id><gtr:otherNames>Whitcomb DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>5675ec45b82e2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4158971-78C7-4198-9204-9838E14B3791</gtr:id><gtr:title>Distinct cerebellar engrams in short-term and long-term motor learning.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbc349d2fc465d67b54b7c17905208d7"><gtr:id>fbc349d2fc465d67b54b7c17905208d7</gtr:id><gtr:otherNames>Wang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_5435b0b5b0b7e7d37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C2BE469-3BAA-4E5D-8939-42B85513BC0F</gtr:id><gtr:title>Motor learning and long-term plasticity of parallel fibre-Purkinje cell synapses require post-synaptic Cdk5/p35.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96e43fe3ab77352db7886a85b9ddb0c9"><gtr:id>96e43fe3ab77352db7886a85b9ddb0c9</gtr:id><gtr:otherNames>Moln?r E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>544f9c02b869c6.29486195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15A93A71-B8F0-4AB5-B4A6-E897869575FA</gtr:id><gtr:title>Target- and input-dependent organization of AMPA and NMDA receptors in synaptic connections of the cochlear nucleus.</gtr:title><gtr:parentPublicationTitle>The Journal of comparative neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a511b7b345e672b7768a259262aecb49"><gtr:id>a511b7b345e672b7768a259262aecb49</gtr:id><gtr:otherNames>Rubio ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9967</gtr:issn><gtr:outcomeId>544f9c0329dfd1.54829980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A438C74-14E9-49E5-951F-56CB03B83B53</gtr:id><gtr:title>Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5f2e9c2e1a91a6af42ceb9acd5a7d2"><gtr:id>fd5f2e9c2e1a91a6af42ceb9acd5a7d2</gtr:id><gtr:otherNames>Sapkota K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>5a2fd3d50426a3.89435714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82D1543E-2379-43B1-980A-2DEBF4CA08B5</gtr:id><gtr:title>Pharmacological characterisation of new kainate receptor antagonits</gtr:title><gtr:parentPublicationTitle>JOURNAL OF NEUROCHEMISTRY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b4b27d25a196a731787771b6bfd32c9"><gtr:id>6b4b27d25a196a731787771b6bfd32c9</gtr:id><gtr:otherNames>Mallah S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>56ca034c880ce8.27465174</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J015938/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>DDA3AC5B-B4B5-4323-988E-62B85A8966BF</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Receptors</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F439A20B-A9B0-4A68-B703-7F6AE7570E39</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Systems neuroscience</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>